Skip to content
Industrial Relations, Medical Health Aged Care

Bolton Clarke nurses and carers to hold stop-work rally

Australian Nursing and Midwifery Federation (Victorian Branch) 2 mins read

WHAT
ANMF Bolton Clarke members two-hour stop work and community rally for fair pay and conditions
ACTU Secretary Sally McManus and VTHC Secretary Luke Hilakari will address the rally

WHEN
Monday, 22 July 2024, 1pm-3pm. (Speakers will start 1.05pm sharp)

WHERE
outside Bolton Clarke’s Victorian headquarters, 347 Burwood Highway, Forest Hill

 

Bolton Clarke nurses, personal care workers and midwives will stop work for two hours on Monday 22 July to rally for better pay and conditions.

For the past 18 months, the Australian Nursing and Midwifery Federation (Victorian Branch) has been negotiating wages and conditions on behalf of about 1700 members working across Bolton Clarke’s 22 residential aged care facilities, at-home nursing program, Homeless Persons Nursing Program and maternal and child health line.

Bolton Clarke’s Victorian aged care facilities are located across Melbourne, Geelong and the Mornington Peninsula.

After initially making a zero per cent wage offer, Bolton Clarke has offered a one-year agreement with a two per cent pay increase on some of the lowest rates in Victoria and a new lower pay rate scale for new employees. ANMF is seeking improved conditions and a minimum four per cent increase to match the wages of more competitive aged care providers. 

Members began stage one protected industrial action on Monday 15 July, including wearing red campaign t-shirts at work, talking about their campaign with residents, clients, the media and the community, writing campaign messages on work cars, a ban on redeployment, and administrative and non-clinical documentation bans. 

Bolton Clarke, Australia’s largest not-for-profit aged care provider, wrote to ANMF on 11 July foreshadowing it would ‘take employer response action under section 411 of the Fair Work Act, by way of lockout.’

The major national Queensland-based organisation formed in 2016 when RSL Care in Queensland merged with Victoria’s Royal District Nursing Service. In 2022 it acquired 22 Allity and McKenzie nursing homes in Victoria.

ANMF (Vic Branch) Secretary Lisa Fitzpatrick said: ‘Nurses, carers and midwives only take industrial action as a last resort when their employer is not listening and we reassure residents and clients and their families that their health, safety and welfare are not at risk.’


About us:

The ANMF (Vic Branch) has more than 100,000 members – nurses, midwives and aged care personal care workers – across the Victorian health and aged care sectors.


Contact details:

Robyn Asbury 0417 523 252 │ rasbury@anmfvic.asn.au

Media

More from this category

  • Medical Health Aged Care
  • 31/10/2024
  • 17:55
Kyowa Kirin Co., Ltd.

Kyowa Kirin Announces Changes in Top Leadership Positions to Strengthen Operations as a Global Specialty Pharmaceutical Company

Masashi Miyamoto to be named Chairman and CEO Abdul Mullick to be named President and COO Changes designed to further deliver on company’s 2030…

  • Contains:
  • Medical Health Aged Care
  • 31/10/2024
  • 12:10
MannKind

First Site Initiated in Australia for MannKind’s Phase 3 Clinical Trial Evaluating Clofazimine Inhalation Suspension for the Treatment of Nontuberculous Mycobacterial (NTM) Lung Disease

ICoN-1 study presentation planned November 1 at NTM Symposium AustraliaStudy is cleared by health authorities to proceed in Australia, U.S., Japan and South Korea, with Taiwan anticipated by end of year DANBURY, Conn., Oct. 30, 2024 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of innovative inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases, announced today that it has initiated its first site for its Phase 3 clinical trial evaluating efficacy and safety of Clofazimine Inhalation Suspension for the treatment of nontuberculous mycobacterial (NTM) lung disease. The study,…

  • Business Company News, Medical Health Aged Care
  • 31/10/2024
  • 11:03
Firebrick Pharma

Agreement Signed to Market Nasodine to Healthcare Professionals in Singapore

Firebrick Pharmais pleased to announce that it has executed a Marketing Representation Agreement (the “Agreement”) with Singapore-based, Innorini, trading as Innorini Life Sciences (“Innorini”). The initial term of the Agreement is one year with the option to renew for subsequent one-year terms by mutual agreement. Under the Agreement, Innorini will undertake “Marketing Services” commencing 1 November 2024. The Marketing Services comprise sampling and promotion of Nasodine® Nasal Spray (“Nasodine”) to General Practitioners (“GPs”) and hospital-based doctors and pharmacists (collectively “HCPs”) in Singapore. In addition to building awareness and support of Nasodine by HCPs, Innorini will be expected to sell Nasodine…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.